Estrella Immunopharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Estrella Immunopharma stock has a target of 16, which predicts an increase of 2,005.26% from the current stock price of 0.76.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$16	$16	$16
Change	+2005.3%	+2005.3%	+2005.3%	+2005.3%

* Price targets were last updated on Feb 21, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Estrella Immunopharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $16	Strong Buy	Maintains	$16	+2,005.26%	Feb 21, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Initiates $16	Strong Buy	Initiates	$16	+2,005.26%	Feb 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

506.75M

from 100.84M

402.53%

from 100.84M

Revenue Next Year

n/a

from 506.75M

EPS This Year

-0.47

from -0.27

EPS Next Year

-0.77

from -0.47

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027	Jun 30, 2028	Jun 30, 2029
Revenue	-	-	-	100.84M	506.75M
Revenue Growth	-	-	-	-	402.53%	-	-	-
EPS	-	-	-36.35	-0.27	-0.47	-0.77	-0.95	-0.32
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	3	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.48	-0.79	-0.98
Avg	-0.47	-0.77	-0.95
Low	-0.45	-0.74	-0.91

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.